Adicet Bio, Inc. (ACET) vs Kalaris Therapeutics Inc (KLRS)
A side-by-side comparison of Adicet Bio, Inc. and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACET
Adicet Bio, Inc.
$6.36HealthcareDelayed quote: Oct 6, 2026, 2:49 PM EDT
KLRS
Kalaris Therapeutics Inc
$2.82HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
Total return — ACET vs KLRS
growth of $100 · dividends reinvested · last 9yACET -99.7% (-46.8%/yr)KLRS -99.1% (-40.4%/yr)KLRS compounded faster over this window
ACET KLRS
ACET vs KLRS: by the numbers
- •KLRS is the larger company ($62M vs $59M market cap).
Metrics side by side
Valuation
| Metric | ACET | KLRS |
|---|---|---|
| P/B ratio | 0.49 | 1.07 |
Profitability
| Metric | ACET | KLRS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -82.38% | -76.75% |
| ROIC | -79.68% | -52.40% |
Growth (annualized)
| Metric | ACET | KLRS |
|---|---|---|
| Total return CAGR (5Y) | -44.24% | -81.13% |
Frequently asked
- How have ACET and KLRS total returns compared?
- Over the past 5 years, ACET delivered -44.24% and KLRS delivered -81.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.